Panuramine
![]()  | |
| Clinical data | |
|---|---|
| ATC code | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | 
  | 
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H25N3O2 | 
| Molar mass | 387.483 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
Panuramine (Wy-26,002) is an antidepressant which was synthesized in 1981 by Wyeth.[1] It acts as a potent and selective serotonin reuptake inhibitor (SSRI).[2] It was never marketed.[1]
See also
References
- 1 2 David J. Triggle (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 0-412-46630-9.
 - ↑ Blurton PA, Broadhurst AM, Cross JA, Ennis C, Wood MD, Wyllie MG (September 1984). "Panuramine, a selective inhibitor of uptake of 5-hydroxytryptamine in the brain of the rat". Neuropharmacology. 23 (9): 1049–52. doi:10.1016/0028-3908(84)90127-8. PMID 6514142. S2CID 27269043.
 
| DATTooltip Dopamine transporter (DRIsTooltip Dopamine reuptake inhibitors)  | 
  | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NETTooltip Norepinephrine transporter (NRIsTooltip Norepinephrine reuptake inhibitors)  | 
  | ||||||||||||||
| SERTTooltip Serotonin transporter (SRIsTooltip Serotonin reuptake inhibitors)  | 
  | ||||||||||||||
| VMATsTooltip Vesicular monoamine transporters | 
  | ||||||||||||||
| Others | 
 
  | ||||||||||||||
See also: Receptor/signaling modulators • Monoamine releasing agents • Adrenergics • Dopaminergics • Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins  | |||||||||||||||
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
